We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Agency Cites Five Drug Compounders on Sterility, Adulteration Concerns
Agency Cites Five Drug Compounders on Sterility, Adulteration Concerns
The FDA has cited five U.S.-based drug compounders in as many weeks, with most of the complaints focusing on sterility issues, although questions of adulteration and issuing unapproved drugs also surfaced.